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Abstract: The deficiency of human carbonic anhydrase II (HCAII) has been recognized to 
be associated with a disease called CAII deficiency syndrome (CADS). Among the many 
mutations, the P237H mutation has been characterized to lead to a significant decrease in 
the activity of the enzyme and in the Gibbs free energy of folding. However, sequence 
alignment indicated that the 237th residue of CAII is not fully conserved across all species. 
The  FoldX  theoretical  calculations  suggested  that  this  residue  did  not  significantly 
contribute to the overall folding of HCAII, since all mutants had small G values (around 
1 kcal/mol). The experimental determination indicated that at least three mutations affect 
HCAII  folding  significantly  and  the  P237H  mutation  was  the  most  deleterious  one, 
suggesting  that  Pro237  was  important  to  HCAII  folding.  The  discrepancy  between 
theoretical and experimental results suggested that caution should be taken when using the 
prediction methods to evaluate the details of disease-related mutations. 
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1. Introduction 
The successful folding to its native structure ensures that the protein functions correctly, while the 
appropriate stability determines the life cycle of the protein in the cell. When the protein is incorrectly 
folded or prone to be misfolded, the aberrant structure may lead to loss-of-function or gain-of-function 
of  proteins,  which  has  been  associated  to  many  serious  diseases  [1].  Particularly,  many  familial 
conformational diseases are caused by single point mutations [2]. Thus the elucidation of how these 
disease-related mutations affect the structure and stability of proteins not only helps us to discover the 
molecular  mechanism  of  the  corresponding  disease,  but  also  facilitates  our  understanding  of  the 
structure-function  relationship  of  these  proteins.  To  evaluate  the  mutations  on  protein  stability 
quantitatively, two possible ways are available: one is by experimental work (for example, [3–8]) and 
the other is by prediction (for example, [9–14]). 
Carbonic anhydrase (CA), a member of a large zinc metalloenzyme family, catalyzes the reversible 
reaction in which carbondioxide is hydrated into bicarbonate [15]. In higher vertebrates, there are 
several CA isoenzymes with dissimilar cellular and tissue distributions [15,16]. The deficiency of 
human CA II (HCAII) has been recognized to be associated with a disease called CAII deficiency 
syndrome (CADS)  [17].  Particularly,  the  deficiency  of  HCAII  can  be  caused  by  single-point 
mutations [16,18], which may severely affect HCAII catalytic properties and stability [4,5,19]. Among 
these mutations, the P237H mutation was found to significantly decrease the catalytic efficiency and 
stability of HCAII, suggesting that this mutation may lead to loss-of-function of HCAII and further 
result in HCAII deficiency [5]. P237 is located on the surface of the HCAII molecule (Figure 1), and is 
not involved in the active site or core structure of the enzyme. However, the dramatic decrease in the 
reduction of the Gibbs free energy of HCAII folding implied that it might be crucial to the correct 
packing of the adjacent secondary structures [5]. 
Figure 1. (A) Crystal structure of HCAII (PDB ID 2CBA). Pro237 is highlighted by 
space-filling model; (B) Sequence alignment of CAII. 
 
In this research, multiple sequence alignment was performed to check whether the 237th residue is 
highly conserved across species. Surprisingly, the sequence alignment indicated that the 237th residue 
is not fully conserved. It is Ala in CAs from Mus musculus, Rattus norvegicus and Oncorhynchus 
mukiss, and Thr in CAs from Xenopus tropicalis and Xenopus laevis (Figure 1). To investigate the role Int. J. Mol. Sci. 2011, 12                       
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of the 237th residue in HCAII structure and folding, the effect of substitutions of Pro by various amino 
acid residues at position 237 was studied by both FoldX prediction and folding experiments. The 
results indicated that all mutations caused a minor decrease of the Gibbs free energy of HCAII stability 
when evaluated by FoldX prediction. The experimental results were consistent with the prediction for 
most mutations except P237H. Since the mutations mainly affect the stability of the molten globular 
intermediate, it might be difficult for the algorithm to predict the changes of the Gibbs free energy of 
non-native states of proteins. 
2. Results and Discussion 
2.1. Stability Changes by Mutations of the 237th Residue Predicted by FoldX 
The  effect  of  the  disease-related  mutation  P237H  on  HCAII  folding  has  been  investigated 
previously, and it was found that this mutation led to a ~7.3 kcal/mol decrease of HCAII stability [5]. 
However, sequence alignment analysis indicated that the 237th residue is not fully conserved in CAII, 
and Ala and Thr also appear in the CAII sequence from the other species (Figure 1). An unresolved 
question is whether the position 237 of CAII has any amino acid residue preference? To elucidate this 
problem, the mutation-induced stability changes were evaluated by the prediction of FoldX [20], a 
well-established method that has been successfully applied to the analyses of protein folding [14,21], 
protein design [22], protein-protein interactions [23,24], protein-DNA binding [25] and evolution [26] 
in  a  variety  of  proteins.  The  prediction  was  carried  out  using  the  standard  procedures,  and  the 
“RepairPDB” command was performed before calculation to minimize the FoldX free energy for the 
WT structure at 25 C.  
As shown in Figure 2, all the mutations tested had small G values around 1 kcal/mol, and the 
largest change in stability was found to be caused by the P- > I mutation with a value of 1.22 kcal/mol. 
These results suggest that according to the FoldX prediction, the substitution of Pro at position 237 by 
any  of  the  other  residues  did  not  significantly  affect  HCAII  stability.  In  other  words,  Pro237 
contributed little to the overall stability of the protein. The large discrepancy between the experimental 
data (G = 7.3 kcal/mol) and the prediction (G = 1.03 kcal/mol) of the P237H mutation suggested 
that the role of Pro237 in HCAII might not be well evaluated by FoldX. In this case, it is necessary to 
determine the changes in Gibbs free energy by experimental methods. Five typical mutations (P237A, 
P237T, P237N, P237I, P237F) were chosen for further analysis by folding studies. The choice of 
P237A and P237T was due to the appearance of these two residues in the sequence of the other 
species (Figure 1). The other three mutations were chosen because according to the FoldX results 
shown in Figure 2, P237F was the most stable one among the mutants, while P237I and P237 N were 
the most unstable ones among the possible 20 natural amino acids. Int. J. Mol. Sci. 2011, 12                       
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Figure 2. The changes in the Gibbs free energy induced by mutations predicted by FoldX. 
 
 
2.2. Characterization of the Mutants 
HCAIIpwt,  which  contains  a  C206S  mutation  to  avoid  the  interference  of  unexpected  disulfide 
formation, was used in this study. Previous studies have shown that HCAIIpwt have indistinguishable 
folding and functional properties from the wild type protein [27–31]. All recombinant proteins could 
be successfully obtained in the soluble fraction when overexpressed in E. coli. The activities of the 
mutants were similar to HCAIIpwt, ranging from 87% to 99% of the activity of HCAIIpwt (Table 1). The 
effect of the mutations on HCAII structure was investigated by circular dichrosim (CD) (Figure 3) and 
intrinsic fluorescence (data not shown, see also Figure 4) experiments. The spectra of the mutants were 
almost superimposed with those of HCAIIpwt, suggesting that the mutations did not affect either the 
secondary or the tertiary structures of HCAIIpwt. 
Table 1. Relative activity and the thermodynamic parameters of HCAIIpwt and the mutants. 
G and G are presented in kcal/mol, and m is in kcal mol
−1 M
−1 (GdnHCl). The G 
values were obtained by subtracting the G values of HCAIIpwt from that of the mutants. 
The activity of the enzymes was normalized by taking HCAIIpwt as 100%. 
Enzyme  GNI   GIU  GNU  GNU  mNI  mIU  Activity(%)  
HCAIIpwt  5.7 ±  0.6  7.8 ±  0.6  13.5  0  6.3 ±  0.6  3.9 ±  0.2  100 
HCAIIP237A  6.5 ±  0.7  6.0 ±  0.4  12.5  1.0  6.5 ±  0.7  2.8 ±  0.2  87 
HCAIIP237T  4.7 ±  0.5  6.4 ±  0.4  11.1  2.4  5.2 ±  0.6  3.0 ±  0.2  99 
HCAIIP237N  5.0 ±  0.7  7.3 ±  0.5  12.3  1.2  5.5 ±  0.8  3.6 ±  0.3  93 
HCAIIP237I  5.1 ±  0.5  7.5 ±  0.4  12.6  0.9  6.2 ±  0.6  3.7 ±  0.2  91 
HCAIIP237F  5.3 ±  0.6  5.3 ±  0.3  10.6  2.9  6.3 ±  0.7  2.5 ±  0.1  91 
HCAIIP237H  −  −  −  7.3  −  −  − 
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Figure 3. Far-UV CD spectra of HCAIIpwt and the mutants. 
 
 
Figure  4.  Unfolding  transition  curves  of  HCAIIpwt  and  the  mutants  monitored  by  the 
maximum wavelength of the intrinsic Trp fluorescence. The raw data were fitted by a 
three-state model and presented as solid lines. 
 
2.3. Evaluation of the Stability Changes by GdnHCl-Induced Folding Experiments 
The  HCAII  sequence  contains  seven  Trp  residues  distributed  throughout  the  folded  protein 
structure, thus the conformational changes of the proteins can be sensitively monitored by intrinsic Trp 
fluorescence. The emission maximum wavelength of the intrinsic Trp fluorescence was measured at 
each GdnHCl concentration tested, and the results are presented in Figure 4. Consistent with previous 
observations [5,27,28], the transition curves of all proteins were a three-state process with a molten 
globular intermediate state (I) appearing between the native (N) and the unfolded (U) state. By fitting 
the transition curves into the three-state model NIU, the Gibbs free energy of the two transitions Int. J. Mol. Sci. 2011, 12                       
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was obtained, and the changes in stability (G) were calculated accordingly for each mutant (Table 1). 
The G values of HCAIIpwt were similar to those in literature [4,5], and the minor deviations might be 
caused by different experimental procedures. 
Most mutations slightly destabilize both the NI and IU transitions except P- > A mutation 
seems to stabilize the NI transition. The G values of folding were between 0.9 and 2.9 kcal/mol. 
The most destabilized mutation was P- > F, while the least was P- > I. This observation was quite 
different  from  the  FoldX  prediction,  which  indicated  that  HCAIIP237I  was  the  most  unstable  and 
HCAIIP237F  was  the  most  stable  mutant.  The  large  discrepancy  between  the  theoretical  and 
experimental G values for the three mutants HCAIIP237T, HCAIIP237F and HCAIIP237H (Figure 5) 
suggested that the effects of these mutations could not be predicted correctly. One possible reason is 
that the FoldX has a correlation coefficient of 0.81 and a standard deviation of 0.46 kcal/mol [20], 
and another may be that the prediction can give reasonable data of a large data set but not for the 
details of a small set, as indicated by other authors [32]. Nonetheless, the large experimental G 
values (>2 kcal/mol) caused by the P237T, P237F and P237H mutations implied that the position  
237 of CAII should play a role in CAII stability, and the disease-related mutation P237H was the  
most deleterious. 
Figure 5. Correlation between the FoldX prediction and the experimental measurements. 
 
3. Experimental Section 
3.1. Materials 
Tris, sulfuric acid, ultra pure guanidine hydrochloride (GdnHCL), p-nitrophenol acetate(p-NPA) 
and isopropyl-β-D-thiogalactopyranoside (IPTG) were purchased from Sigma. All the other chemicals 
were local products of analytical grade. Int. J. Mol. Sci. 2011, 12                       
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3.2. Site-Directed Mutagenesis 
According to the previous report, a pseudo wild type HCAII (HCAIIpwt) was used in this research. 
This pseudo wild type protein was constructed with the mutation C206S to avoid possible interference 
from the folding of HCAII by incorrect disulfide formation since Cys206 is the only Cys in HCAII. 
Previous study has shown that HCAIIpwt has the same catalytic properties and folding as the wild 
type HCAII  [27].  The  mutated  proteins  were  obtained  by  site  directed  mutagenesis  using  the 
following primers:  
HCAIIP237I-For, 5'-CAATGGGGAGGGTGAAATCGAAGAACTGATG-3';  
HCAIIP237I-Rev, 5'-CATCAGTTCTTCGATTTCACCCTCCCCATTG-3';  
HCAIIP237N-For, 5'-CAATGGGGAGGGTGAAAACGAAGAACTGATG-3';  
HCAIIP237I-Rev, 5'-CATCAGTTCTTCGTTTTCACCCTCCCCATTG-3';  
HCAIIP237F-For, 5'-CAATGGGGAGGGTGAATTCGAAGAACTGATG-3';  
HCAIIP237F-Rev, 5'-CATCAGTTCTTCGAATTCACCCTCCCCATTG-3';  
HCAIIP237A-For, 5'-CAATGGGGAGGGTGAAGCCGAAGAACTGATG-3';  
HCAIIP237A-Rev, 5'-CATCAGTTCTTCGGCTTCACCCTCCCCATTG-3';  
HCAIIP237T-For, 5'-CAATGGGGAGGGTGAAACCGAAGAACTGATG-3';  
HCAIIP237T-Rev, 5'-CATCAGTTCTTCGGTTTCACCCTCCCCATTG-3'.  
Site-directed mutations were carried out using standard procedures. The genes were cloned into 
PET28b vector (Novagen) and a 6-His tag were added at the C-terminus of the protein to facilitate 
protein purification. 
3.3. Protein Expression and Purification 
HCAIIpwt and the mutated proteins were overexpressed in E. coli Rosseta(DE3) in LBkan at 37 C, 
and the induction of overexpression was achieved by the addition of 0.5 mM IPTG and 0.5 mM 
ZnSO4. The bacterial cells were harvested by centrifugation, sonicated and the target proteins were 
purified  by  Ni-NTA  affinity  chromatography  (QIAGEN)  as  described  previously  [5].  The  final 
products were collected on a Superdex 75 HR 10/30 (GE Healthcare Life Sciences), and only the peak 
containing  the  monomeric  form  were  collected.  The  protein  concentration  were  determined  by 
measuring the absorbance at A280 using ε280 nm = 53,800 M
−1 cm
−1. 
3.4. Activity Assay 
The enzymatic activity of HCAIIpwt and the mutants were determined by the esterase activity assay, 
which  monitors  the  appearance  of  p-nitrophenolate  anion  spectrophototometrically  during  the 
hydrolysis of p-NPA [33]. The 1-mL assay mixtures contained 1 mM pNPA, 3% acetone and 10 mM 
Tris-H2SO4, pH 7.5. The reaction was started by the addition of 1.5 M enzyme, and the hydrolysis of 
pNPA to pNP was monitored by following the increase in absorbance at 348 nm at 25 C. The final 
value was obtained by subtracting the background values for the non-catalyzed ester hydrolysis. Int. J. Mol. Sci. 2011, 12                       
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3.5. Protein Folding Experiments 
The unfolding of HCAIIpwt and the mutated proteins were performed by incubating the proteins in 
10 mM Tris-H2SO4 buffer, pH 7.5, in the presence of various concentrations of GdnHCl for 16 h at 
25 ° C.  Then  spectroscopic  experiments  were  performed  to  monitor  the  structural  changes  of  the 
samples. The final protein concentration was 0.8 M. The unfolding data were fitted to a three-state 
folding model as described previously [5]. 
3.6. Spectroscopic Measurements 
The intrinsic Trp fluorescence was measured using a 1 cm path-length quartz cuvette on a Hitachi 
F-4500 spectrophotometer at 25 ° C. The excitation wavelength was 295 nm with both the entrance and 
exit slits of 5 nm, and the emission spectra were collected between 300 nm and 450 nm. The Far-UV 
circular dichroism (CD) spectra were recorded on a Jasco-715 spectrophotometer (Tokyo, Japan) over 
a wavelength range of 190–250 nm using the 0.1 cm path-length cells. The protein concentration for 
CD experiments was 1.5 M. The presented spectra were the average of three repetitions. 
3.7. Changes in Gibbs Free Energy Calculated by FoldX 
The changes in the Gibbs free energy (G) induced by mutations at position 237 were calculated 
by  FoldX  (version  3.0  beta3)  [20].  The  structure  of  the  wild  type  protein (PDB  ID:  2CBA)  was 
minimized using the “RepairPDB” command to identify the residues that had bad torsion angles, van 
der Waal’s clashes or total energies belonging to the complex interface. Then individual mutations 
were  built  using  “BuildModel”  command  and  the  G  values  were  extracted  from  the  FoldX 
output files. 
4. Conclusions 
Sequence  alignment  indicated  that  the  237th  residue  of  CAII  is  not  fully  conserved  across  all 
species.  However,  the  P237H  mutation  of  HCAII  has  been  characterized  to  be  a  disease-related 
mutation that significantly destabilizes the protein. The FoldX theoretical calculations suggested that 
this  residue  did  not  significantly  contribute  to  the  overall  folding  of  HCAII  since  a  small  G 
value (around 1 kcal/mol) was obtained when substituting Pro237 by any other naturally occurring 
amino acid. The experimental studies indicated that at least three mutations significantly affected the 
GdnHCl-induced unfolding of HCAII, suggesting that Pro237 is important to HCAII folding. The 
results also showed that the P237H mutation was the most deleterious among the 19 mutations. The 
discrepancy between theoretical and experimental results suggested that caution should be taken when 
using the prediction methods to evaluate the details of disease-related mutations. 
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